2024-03-29T10:01:33Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_3CA002AEBD9B
2024-03-23T02:14:17Z
serval:BIB_3CA002AEBD9B
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.
10.1097/QAI.0b013e3181dd911e
20431394
000281170500006
Post
F.A.
author
Moyle
G.J.
author
Stellbrink
H.J.
author
Domingo
P.
author
Podzamczer
D.
author
Fisher
M.
author
Norden
A.G.
author
Cavassini
M.
author
Rieger
A.
author
Khuong-Josses
M.A.
author
Branco
T.
author
Pearce
H.C.
author
Givens
N.
author
Vavro
C.
author
Lim
M.L.
author
article
2010
Journal of Acquired Immune Deficiency Syndromes
1944-7884[electronic], 1525-4135[linking]
journal
55
1
49-57
Adenine/administration & dosage
Adenine/adverse effects
Adolescent
Adult
Aged
Anti-HIV Agents/administration & dosage
Anti-HIV Agents/adverse effects
Benzoxazines/administration & dosage
Benzoxazines/adverse effects
Deoxycytidine/administration & dosage
Deoxycytidine/adverse effects
Dideoxynucleosides/administration & dosage
Dideoxynucleosides/adverse effects
Drug Combinations
Female
Glomerular Filtration Rate/drug effects
HIV Infections/drug therapy
HIV-1/isolation & purification
Humans
Kidney/drug effects
Lamivudine/administration & dosage
Lamivudine/adverse effects
Male
Middle Aged
Phosphonic Acids/administration & dosage
Phosphonic Acids/adverse effects
Retinol-Binding Proteins/urine
Treatment Outcome
Viral Load
Young Adult
beta 2-Microglobulin/urine
eng
60_published
Publication types: Comparative Study ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
Publication Status: ppublish